本页面由Tiger Trade Technology Pte. Ltd.提供服务

Janux Therapeutics, Inc.

15.04
-0.2000-1.31%
盘后15.02-0.0200-0.13%19:05 EDT
成交量:98.76万
成交额:1,470.90万
市值:9.15亿
市盈率:-8.20
高:15.13
开:14.68
低:14.60
收:15.24
52周最高:35.34
52周最低:12.12
股本:6,083.17万
流通股本:4,168.06万
量比:1.32
换手率:2.37%
股息:- -
股息率:- -
每股收益(TTM):-1.8336
每股收益(LYR):-1.8336
净资产收益率:-11.48%
总资产收益率:-9.55%
市净率:0.96
市盈率(LYR):-8.20

数据加载中...

2024/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities